CAG
AMGN icon

Centerpoint Advisory Group’s Amgen AMGN Stock Holding History

Centerpoint Advisory Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,153
Closed -$359K – 101
2025
Q1 		$359K Hold
1,153
– – 0.35% 65
2024
Q4 		$301K Buy
+1,153
New +$342K 0.29% 68

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Centerpoint Advisory Group's AMGN Position: Q2 2025 in Review

Centerpoint Advisory Group sold out of Amgen (AMGN) in Q2 2025, closing a stake of 1,153 shares — an estimated $359K sold.

Centerpoint Advisory Group first reported a position in AMGN in Q4 2024 and held it in 2 quarters. The position peaked at $359K in Q1 2025. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Centerpoint Advisory Group reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Centerpoint Advisory Group sold 1,153 Amgen shares in Q2 2025, an estimated $359K.
  • Centerpoint Advisory Group first reported a position in Amgen in Q4 2024 and held it in 2 quarters.
  • Centerpoint Advisory Group's Amgen position peaked at $359K in Q1 2025.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Centerpoint Advisory Group's 13F filing for Q2 2025, filed 6 Aug 2025.